Drugmakers are eyeing GLP-1 drugs, with their high levels of weight loss, as a p...
The movement to embrace state execution by means of nitrogen has a troubling new...
The upcoming Clinical Trial Supply Europe 2024 conference will round-up pharma a...
Merck's KEYTRUDA has received a positive opinion from the EMA CHMP for use in co...
SK bioscience has achieved a significant milestone with its typhoid conjugate va...
Moderna has announced the conclusion of construction works at its new mRNA manuf...
The US FDA has granted approval for Alvotech and Teva Pharmaceuticals’ SIMLANDI ...
Bayer’s oral tyrosine kinase inhibitor is currently in a Phase I trial estimated...
The Phase II prospective, randomised trial will evaluate three doses of PKM-01 t...
The EMA's decision on the marketing authorisation application for Biogen Qalsody...
"With rare exceptions, all 40-year-olds are alike. ... When you have seen one 85...
AstraZeneca has announced the conclusion of its acquisition of Gracell Biotechno...
AbbVie has signed an agreement with Tentarix Biotherapeutics to discover and dev...
The EMA has granted an accelerated review of CHIKV VLP as Bavarian Nordic attemp...
Moderna has reported a net loss of $4.7bn for the full year 2023 as against a ne...
The UK NICE has recommended Pfizer's Ritlecitinib as a new treatment option for ...
